Finding aid
Compounds A–Z
Every compound the Institute has assessed, with its synonyms, development codes and trade names cross-referenced to the monograph.
§1A–Z index
51 compounds and 170 cross-referenced synonyms, development codes and trade names.
#5 entries
- 5-amino-1-methylquinolinium see 5-amino-1MQ
- 5-amino-1MQ Very low
- 5-amino-1MQ iodide see 5-amino-1MQ
- β-nicotinamide adenine dinucleotide see NAD+ (nicotinamide adenine dinucleotide)
- γ-Glu-Cys-Gly see Glutathione
A18 entries
- Ac-LKKTETQ see TB-500
- Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 see Melanotan-II
- AC137 see Pramlintide
- AC2993 see Exenatide
- ACTH(4-7)-Pro-Gly-Pro see Semax
- Adlyxin (trade) see Lixisenatide
- AEDG peptide see Epithalon
- Ala-Glu-Asp-Gly see Epithalon
- alpha-MSH(11-13) see KPV
- ALX-0600 see Teduglutide
- AM833 see Cagrilintide
- AMG 133 see Maridebart cafraglutide
- Amycretin Low
- amycretin (INN) see Amycretin
- AOD-9604 Very low
- AOD9604 see AOD-9604
- AT-1001 see Larazotide acetate
- AVE0010 see Lixisenatide
B8 entries
- Bendavia see SS-31 (elamipretide)
- Bepecin see BPC-157
- BI 456906 see Survodutide
- body protection compound 157 see BPC-157
- BPC-157 Very low
- bremelanotide see PT-141 (bremelanotide)
- Bydureon (trade) see Exenatide
- Byetta (trade) see Exenatide
C10 entries
- Cagrilintide Moderate
- cagrilintide (INN) see Cagrilintide
- cagrilintide 2.4 mg / semaglutide 2.4 mg see CagriSema (cagrilintide with semaglutide)
- CagriSema see CagriSema (cagrilintide with semaglutide)
- CagriSema (cagrilintide with semaglutide) Moderate
- CAP-18(104-140) see LL-37
- CJC-1295 Low
- CJC-1295 DAC see CJC-1295
- CJC-1295 with DAC see CJC-1295
- copper tripeptide-1 see GHK-Cu
D9 entries
- DAC:GRF see CJC-1295
- Danuglipron Low
- danuglipron (INN) see Danuglipron
- delta sleep-inducing peptide see DSIP
- diphosphopyridine nucleotide see NAD+ (nicotinamide adenine dinucleotide)
- DSIP Very low
- DSIP nonapeptide see DSIP
- Dulaglutide High
- dulaglutide (INN) see Dulaglutide
E11 entries
- Ecnoglutide Low
- ecnoglutide (INN) see Ecnoglutide
- Egrifta (trade) see Tesamorelin
- elamipretide see SS-31 (elamipretide)
- EP-23905 see Hexarelin
- epitalon see Epithalon
- epithalamin tetrapeptide see Epithalon
- Epithalon Very low
- examorelin see Hexarelin
- Exenatide High
- exendin-4 see Exenatide
G15 entries
- Gattex (trade) see Teduglutide
- geref see Sermorelin
- GHK copper complex see GHK-Cu
- GHK-Cu Low
- GHRP-2 Low
- GHRP-6 Very low
- Glutathione Low
- glycyl-L-histidyl-L-lysine copper(II) see GHK-Cu
- GnRH see Gonadorelin
- Gonadorelin Moderate
- gonadorelin (INN) see Gonadorelin
- GPA-748 see GHRP-2
- GRF(1-29) see Sermorelin
- growth hormone releasing peptide-6 see GHRP-6
- GSH see Glutathione
H8 entries
- hCAP18 fragment see LL-37
- heptapeptide Selank see Selank
- heptapeptide Semax see Semax
- Hexarelin Very low
- hexarelin (INN) see Hexarelin
- hGH fragment 176-191 (Tyr-modified) see AOD-9604
- His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 see GHRP-6
- human cathelicidin LL-37 see LL-37
I6 entries
- IBI362 see Mazdutide
- IGF-1 Long Arg3 see IGF-1 LR3
- IGF-1 LR3 Very low
- INN-202 see Larazotide acetate
- Ipamorelin Low
- ipamorelin (INN) see Ipamorelin
K5 entries
- Kisspeptin-10 Low
- kisspeptin-54 C-terminal decapeptide see Kisspeptin-10
- KP-10 see Kisspeptin-10
- KP-102 see GHRP-2
- KPV Very low
L19 entries
- L-glutathione reduced see Glutathione
- larazotide (INN) see Larazotide acetate
- Larazotide acetate Moderate
- LHRH see Gonadorelin
- Liraglutide High
- liraglutide (INN) see Liraglutide
- Lixisenatide Moderate
- lixisenatide (INN) see Lixisenatide
- LL-37 Low
- Long R3 IGF-1 see IGF-1 LR3
- LR3 IGF-1 see IGF-1 LR3
- luteinising hormone-releasing hormone see Gonadorelin
- LY2189265 see Dulaglutide
- LY3298176 see Tirzepatide
- LY3305677 see Mazdutide
- LY3437943 see Retatrutide
- LY3502970 see Orforglipron
- Lys-Pro-Val see KPV
- Lyxumia (trade) see Lixisenatide
M17 entries
- Maridebart cafraglutide Low
- maridebart cafraglutide (INN) see Maridebart cafraglutide
- MariTide see Maridebart cafraglutide
- Mazdutide Moderate
- mazdutide (INN) see Mazdutide
- melanotan 2 see Melanotan-II
- Melanotan-II Very low
- Met-Glu-His-Phe-Pro-Gly-Pro see Semax
- metastin(45-54) see Kisspeptin-10
- mitochondrial open reading frame of the 12S rRNA type-c see MOTS-c
- modified GRF(1-29) (the non-DAC variant) see CJC-1295
- MOTS-c Very low
- MOTS-c peptide see MOTS-c
- Mounjaro (trade) see Tirzepatide
- MT-II see Melanotan-II
- MT2 see Melanotan-II
- MTP-131 see SS-31 (elamipretide)
N12 entries
- NAD see NAD+ (nicotinamide adenine dinucleotide)
- NAD+ see NAD+ (nicotinamide adenine dinucleotide)
- NAD+ (nicotinamide adenine dinucleotide) Very low
- NN2211 see Liraglutide
- NN9535 see Semaglutide
- NN9924 see Semaglutide, oral
- NNC 26-0161 see Ipamorelin
- NNC0113-0217 see Semaglutide
- NNC0174-0833 see Cagrilintide
- NNC0174-0833 + NN9535 see CagriSema (cagrilintide with semaglutide)
- NNC0487-0111 see Amycretin
- NNMT inhibitor 5-amino-1MQ see 5-amino-1MQ
O6 entries
- oral semaglutide see Semaglutide, oral
- Orforglipron Moderate
- orforglipron (INN) see Orforglipron
- OWL833 see Orforglipron
- OXM analogue see Mazdutide
- Ozempic (trade) see Semaglutide
P11 entries
- pentadecapeptide BPC 157 see BPC-157
- Petrelintide Low
- petrelintide (INN) see Petrelintide
- PF-06882961 see Danuglipron
- PL 14736 see BPC-157
- pralmorelin see GHRP-2
- pralmorelin hydrochloride see GHRP-2
- Pramlintide Moderate
- pramlintide (INN) see Pramlintide
- PT-141 see PT-141 (bremelanotide)
- PT-141 (bremelanotide) Moderate
R6 entries
- Retatrutide Moderate
- retatrutide (INN) see Retatrutide
- Revestive (trade) see Teduglutide
- RGN-352 (investigational formulation) see Thymosin beta-4
- Rybelsus (trade) see Semaglutide
- Rybelsus (trade) see Semaglutide, oral
S17 entries
- Saxenda (trade) see Liraglutide
- Selank Low
- Semaglutide High
- semaglutide (INN) see Semaglutide
- semaglutide with SNAC see Semaglutide, oral
- Semaglutide, oral High
- Semax Low
- Sermorelin Low
- sermorelin (INN) see Sermorelin
- sermorelin acetate see Sermorelin
- SKF-110679 see GHRP-6
- SS-31 (elamipretide) Moderate
- SS-31 tetrapeptide see SS-31 (elamipretide)
- Survodutide Moderate
- survodutide (INN) see Survodutide
- Symlin (trade) see Pramlintide
- synthetic exendin-4 see Exenatide
T29 entries
- TB-500 Very low
- TB4 see Thymosin beta-4
- TB4 active fragment see TB-500
- Teduglutide Moderate
- teduglutide (INN) see Teduglutide
- Tesamorelin Moderate
- tesamorelin (INN) see Tesamorelin
- TH9507 see Tesamorelin
- Thr-Lys-Pro-Arg-Pro-Gly-Pro see Selank
- thymalfasin see Thymosin alpha-1
- thymalin see Thymalin
- Thymalin Very low
- Thymosin alpha-1 Moderate
- Thymosin beta-4 Low
- thymosin beta-4 fragment 17-23 (acetylated) see TB-500
- thymosin α1 see Thymosin alpha-1
- thymosin β4 see Thymosin beta-4
- thymus polypeptide extract see Thymalin
- Tirzepatide High
- tirzepatide (INN) see Tirzepatide
- tripeptide KPV see KPV
- triple agonist LY3437943 see Retatrutide
- tripro-amylin see Pramlintide
- Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu see DSIP
- Trulicity (trade) see Dulaglutide
- tuftsin analogue see Selank
- Tyr-hGH(177-191) see AOD-9604
- Tα1 see Thymosin alpha-1
- Tβ4 see Thymosin beta-4
V3 entries
- Victoza (trade) see Liraglutide
- Vilon (related dipeptide preparation) see Thymalin
- Vyleesi (trade) see PT-141 (bremelanotide)
W1 entries
- Wegovy (trade) see Semaglutide
X1 entries
- XW003 see Ecnoglutide
Z4 entries
- Zadaxin (trade) see Thymosin alpha-1
- Zepbound (trade) see Tirzepatide
- ZP10 see Lixisenatide
- ZP8396 see Petrelintide
Compound Evidence Institute · CEI institutional document · https://compoundevidence.com/compounds-index/ · retrieved 30 July 2026